Target Sufficiency Utilizes High Resolution Mass Spec to Quantify Drug Target Proteins

Posted on by

Date/Time: 6/28/23 11:30 AM ET

Measurement sensitivity typically exceeds that of immunoassay platforms and the specificity of MS avoids cross-reactivity/interference issues commonly encountered with antibodies. MS analyses display linearity over a 2-3 log range and yield molar scale quantitation, which enables precise comparisons of target abundance. Target Sufficiency platform assays enable multiplexed assays for efficient sample utilization.

Attendees of this webinar will: 

  • Understand applications for quantitative mass spec including: oncology, gene editing therapeutics validation, RNA therapeutics validation, protein degrading therapeutics validation, animal model characterization.
  • Discover that this technology is not limited by affinity or aptamer reagents.
  • Understand how to design a custom panel of protein targets in less than six weeks.
  • Be aware that this technology may be used to analyze 1 to 100 proteins in nearly any biological sample, including biofluids, tissues, FFPE blocks, and even previously stained slides.

Request Free!